These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24353540)

  • 1. Insulin resistance in non-diabetic patients of chronic Hepatitis C.
    Kiran Z; Zuberi BF; Anis D; Qadeer R; Hassan K; Afsar S
    Pak J Med Sci; 2013 Jan; 29(1):201-4. PubMed ID: 24353540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INSULIN RESISTANCE REDUCTION AFTER SUSTAINED VIROLOGICAL RESPONSE WITH DIRECT ACTING ANTIVIRAL:NOT EVERY POPULATION IMPROVES.
    Andrade VG; Yamashiro FDS; Oliveira CV; Moreira A; Winckler FC; Silva GF
    Arq Gastroenterol; 2018; 55(3):274-278. PubMed ID: 30540091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CURING HEPATITIS C WITH THE NEW DIRECT ACTING ANTIVIRALS DID NOT IMPROVE INSULIN RESISTANCE AFTER ONE YEAR.
    Strauhs-Nitsch L; Campiolo MF; Morsoletto DBG; Pissaia Junior A; Ivantes CAP
    Arq Gastroenterol; 2020; 57(3):267-271. PubMed ID: 33027477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic hepatitis C infection is associated with insulin resistance and lipid profiles.
    Dai CY; Yeh ML; Huang CF; Hou CH; Hsieh MY; Huang JF; Lin IL; Lin ZY; Chen SC; Wang LY; Chuang WL; Yu ML; Tung HD
    J Gastroenterol Hepatol; 2015 May; 30(5):879-84. PubMed ID: 23808794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
    Helaly GF; Hussein NG; Refai W; Ibrahim M
    Transl Res; 2011 Sep; 158(3):155-62. PubMed ID: 21867981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance in nondiabetic Egyptian patients with chronic hepatitis C virus.
    Shawky MA; Mohammed AQ; Hassan AM; Ali BH; Moustafa HM
    Rev Gastroenterol Mex (Engl Ed); 2020; 85(2):173-179. PubMed ID: 31784195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Prevalence of Insulin Resistance Among Iranian Patients with Chronic Hepatitis C Virus Infection: A Case-Control Study.
    Eshraghian K; Lankarani KB; Fattahi MR; Esmailnejad A; Peymani P
    Curr Diabetes Rev; 2018; 14(5):446-450. PubMed ID: 28714382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of hepatitis C virus infection on insulin resistance in chronic haemodialysis patients.
    Ozdemir A; Yalinbas B; Selamet U; Eres M; Turkmen F; Kumbasar F; Murat B; Keskin AT; Barut Y
    Yonsei Med J; 2007 Apr; 48(2):274-80. PubMed ID: 17461527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin levels and insulin resistance among patients with chronic hepatitis C.
    Carvalho RF; Atta AM; de Oliveira IS; Santos TPS; Santos JPA; Schinoni MI; de Sousa-Atta MLB
    Acta Trop; 2018 Feb; 178():258-263. PubMed ID: 29217381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of HCV on fasting glucose, fasting insulin and peripheral insulin resistance in first 5 years of infection.
    Ahmed N; Rashid A; Naveed AK; Bashir Q
    J Pak Med Assoc; 2016 Feb; 66(2):140-2. PubMed ID: 26819155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection.
    Hung CH; Wang JH; Hu TH; Chen CH; Chang KC; Yen YH; Kuo YH; Tsai MC; Lu SN; Lee CM
    World J Gastroenterol; 2010 May; 16(18):2265-71. PubMed ID: 20458764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance/beta-cell function and serum ferritin level in non-diabetic patients with hepatitis C virus infection.
    Furutani M; Nakashima T; Sumida Y; Hirohama A; Yoh T; Kakisaka Y; Mitsuyoshi H; Senmaru H; Okanoue T
    Liver Int; 2003 Aug; 23(4):294-9. PubMed ID: 12895270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients.
    Adinolfi LE; Nevola R; Guerrera B; D'Alterio G; Marrone A; Giordano M; Rinaldi L
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1379-1382. PubMed ID: 29228501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum leptin and homeostasis model assessment-IR as novel predictors of early liver fibrosis in chronic hepatitis B virus infection.
    Mousa N; Abdel-Razik A; Sheta T; Shabana W; Zakaria S; Awad M; Abd Elsalam M; El-Wakeel N; Elkashef W; Effat N; Elgamal A; Deiab AG; Eldars W
    Br J Biomed Sci; 2018 Oct; 75(4):192-196. PubMed ID: 30079841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance and prediabetes in hepatitis C virus patients.
    Desouky DE; Kasemy Z; Abdel-Hamid AE; Omar MS
    Am J Med Sci; 2015 Aug; 350(2):77-80. PubMed ID: 26086154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker potential of C-peptide for screening of insulin resistance in diabetic and non-diabetic individuals.
    Khan HA; Sobki SH; Ekhzaimy A; Khan I; Almusawi MA
    Saudi J Biol Sci; 2018 Dec; 25(8):1729-1732. PubMed ID: 30591792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].
    Hui JM; Sud A; Farrell GC; Bandara P; Byth K; Kench JG; McCaughan GW; George J
    Gastroenterology; 2003 Dec; 125(6):1695-704. PubMed ID: 14724822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-alpha and CXCL-10 correlation with insulin resistance in patients with chronic hepatitis C virus infection.
    Sayed-Ahmed L; Kotb N; El-Serogy H; El-Shazly S; Eid M
    Egypt J Immunol; 2010; 17(1):101-11. PubMed ID: 22053613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of chronic viral hepatitis B with insulin resistance.
    Lee JG; Lee S; Kim YJ; Cho BM; Park JS; Kim HH; Cheong J; Jeong DW; Lee YH; Cho YH; Bae MJ; Choi EJ
    World J Gastroenterol; 2012 Nov; 18(42):6120-6. PubMed ID: 23155341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum aminotransferase.
    Tanaka N; Nagaya T; Komatsu M; Horiuchi A; Tsuruta G; Shirakawa H; Umemura T; Ichijo T; Matsumoto A; Yoshizawa K; Aoyama T; Kiyosawa K; Tanaka E
    Liver Int; 2008 Sep; 28(8):1104-11. PubMed ID: 18397231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.